Additionally, higher S100B levels appear to be correlated with the severity of PE, including neural disturbances and the risk of HELLP syndrome, while postpartum levels may serve as a useful biomarker for the long-term monitoring of CNS injury associated with PE. This evidence concerns the gene S100B and HELLP syndrome.